Phase-I Pilot Study: Investigating objective measures of pain-processing-related nociception and subjective pain perception in an elderly cohort in the presence and absence of a standard analgesic on irritated (UVB) and non-irritated skin

This academic pilot-study – in cooperation with the School of Pharmacy of the University of Waterloo in Ontarion Canada – was completed by end July 2011. The statistical analysis of all experimental data (after online acquisition) was completed. The results confirm earlier findings with the investigated compound, but demonstrate age-related influences.

This is normally a place for German posts only – as we are looking for German-speaking volunteers to take part in our clinical studies!

For more detailed information on our actual clinical studies and designs, please contact
HPR Dr. Schaffler GmbH


Weitere Informationen erhalten Sie im Prüfzentrum HPR Dr. Schaffler GmbH/ Heisenbergbogen 1 (Europa Forum I) in D-85609 Aschheim-Dornach bei München unter der Telefonnummer 089-99322-0, Sprechzeiten von 10-17 Uhr.

Nur ambulante Studien, keine Hospitalisierung!

Sehen Sie auch bei anfallenden Studien unsere aktuellen Anzeigen auf und unter Studienteilnehmer/Probanden<Nützliche Links>

This entry was posted in Clinical Studies on by .

About Klaus Schaffler

Dr. med. Klaus Schaffler (MD) has been specializing in the electrophysiology and pharmacology of the human central nervous system (CNS) – as well as in the field of human experimental pain research. During this development process, HPR Dr. Schaffler GmbH has issued over 175 presentations/ publications (sharing more than 50 on pain/ analgesia) and has conducted more than 150 phase-I studies with quite different objectives.